You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Bromocriptine, a direct dopaminergic receptor agonist, showed significant therapeutic benefits for idiopathic Parkinsonism patients. This drug improved neurological deficits by up to 20% in severely affected individuals.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: